Skip to main content
Free access
Research Article
22 November 2019

Complications and its impact in patients with closed and open tibial shaft fractures requiring open reduction and internal fixation

Abstract

Aim: To evaluate the rates of infection and nonunion and determine the impact of infections on healthcare resource use and costs following open and closed fractures of the tibial shaft requiring open reduction internal fixation. Methods: Healthcare use and costs were compared between patients with and without infections following pen reduction internal fixation using MarketScan® databases. Results: For commercial patients, the rates of infection and nonunion ranged from 1.82 to 7.44% and 0.48 to 8.75%, respectively, over the 2-year period. Patients with infection had significantly higher rates of hospital readmissions, emergency room visits and healthcare costs compared with patients without infection. Conclusion: This real-world study showed an increasing rate of infection up to 2 years and infection significantly increased healthcare resource use and costs.

Supplementary Material

File (suppl_file.docx)

References

Papers of special note have been highlighted as: • of interest; •• of considerable interest
1.
Antonova E, Le TK, Burge R, Mershon J. Tibia shaft fractures: costly burden of nonunions. BMC Musculoskelet. Disord. 14, 42 (2013).
• Compares healthcare use and costs with tibial shaft fractures in patients with and without nonunion.
2.
Metsemakers WJ, Handojo K, Reynders P, Sermon A, Vanderschot P, Nijs S. Individual risk factors for deep infection and compromised fracture healing after intramedullary nailing of tibial shaft fractures: a single centre experience of 480 patients. Injury 46(4), 740–745 (2015).
•• Provides risk factors associated with infection in tibial shaft fractures.
3.
Auston DA, Meiss J, Serrano R et al. Percutaneous or open reduction of closed tibial shaft fractures during intramedullary nailing does not increase wound complications, infection or nonunion rates. J. Orthop. Trauma 31(4), 215–219 (2017).
• Compares complications rates amongst different reduction methods in tibial shaft fractures.
4.
Johal H, Bhandari M, Tornetta P 3rd. Cochrane in CORR (®): Intramedullary nailing for tibial shaft fractures in adults (Review). Clin. Orthop. Relat. Res. 475(3), 585–591 (2017).
•• Provides importance of the topic by summarizing prevalence of tibial shaft fractures, associated treatment and complications.
5.
Sheth U, Bomberg J, Szatkowski J. Tibial shaft fractures (2019). https://www.orthobullets.com/trauma/1045/tibial-shaft-fractures
6.
Moore TM, Patzakis MJ, Harvey JP. Tibial plateau fractures: definition, demographics, treatment rationale, and long-term results of closed traction management or operative reduction. J. Orthop. Trauma 1(2), 97–119 (1987).
7.
Waddell JP, Johnston DW, Neidre A. Fractures of the tibial plateau: a review of ninety-five patients and comparison of treatment methods. J. Trauma 21(5), 376–381 (1981).
8.
Lin S, Mauffrey C, Hammerberg EM, Stahel PF, Hak DJ. Surgical site infection after open reduction and internal fixation of tibial plateau fractures. Eur. J. Orthop. Surg. Traumatol. 24(5), 797–803 (2014).
• Identifies risk factors for surgical site infections.
9.
Shepard J, Ward W, Milstone A et al. Financial impact of surgical site infections on hospitals: the hospital management perspective. JAMA Surg. 148(10), 907–914 (2013).
10.
Kuhn S, Hansen M, Rommens PM. Extending the indication of intramedullary nailing of tibial fractures. Eur. J. Trauma Emerg. Surg. 33(2), 159–169 (2007).
11.
Zura R, Xiong Z, Einhorn T et al. Epidemiology of fracture nonunion in 18 human bones. JAMA Surg. 151(11), e162775 (2016).
12.
Papagelopoulos PJ, Partsinevelos AA, Themistocleous GS, Mavrogenis AF, Korres DS, Soucacos PN. Complications after tibia plateau fracture surgery. Injury 37(6), 475–484 (2006).
13.
Olesen UK, Pedersen NJ, Eckardt H et al. The cost of infection in severe open tibial fractures treated with a free flap. Int. Orthop. 41(5), 1049–1055 (2017).
14.
Use of Real-World Evidence to Support Regulatory Decision-Making for Medical Devices. Guidance for Industry and Food and Drug Administration Staff (2017). https://www.fda.gov/regulatory-information/search-fda-guidance-documents/use-real-world-evidence-support-regulatory-decision-making-medical-devices
15.
Dahabreh Z, Calori GM, Kanakaris NK, Nikolaou VS, Giannoudis PV. A cost analysis of treatment of tibial fracture nonunion by bone grafting or bone morphogenetic protein-7. Int. Orthop. 33(5), 1407–1414 (2009).
16.
Dahabreh Z, Dimitriou R, Giannoudis PV. Health economics: a cost analysis of treatment of persistent fracture non-unions using bone morphogenetic protein-7. Injury 38(3), 371–377 (2007).
17.
Olsen MA, Ball KE, Nickel KB, Wallace AE, Fraser VJ. Validation of ICD-9-CM diagnosis codes for surgical site infection and noninfectious wound complications after mastectomy. Infect. Control Hosp. Epidemiol. 38(3), 334–339 (2017).
18.
Rennert-May E, Manns B, Smith S et al. Validity of administrative data in identifying complex surgical site infections from a population-based cohort after primary hip and knee arthroplasty in Alberta, Canada. Am. J. Infect. Control 46(10), 1123–1126 (2018).
19.
Metsemakers WJ, Morgenstern M, McNally MA et al. Fracture-related infection: a consensus on definition from an international expert group. Injury 49(3), 505–510 (2018).
20.
Heckman JD, Sarasohn-Kahn J. The economics of treating tibia fractures. The cost of delayed unions. Bull. Hosp. Jt Dis. 56(1), 63–72 (1997).
•• Provides the costs associated with delayed union in tibial fractures.